Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 06:15 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
September 25, 2025 02:30 ET | Source: Arecor Therapeutics PLC

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292

Arecor Therapeutics announces Co-development Agreement for AT278 with Sequel Med Tech and Sale of Royalty and Technology Access Fees for up to $11m
September 17, 2025 07:30 ET | Source: Eyenuk

Eyenuk Secures World’s First National Health System Deployment of Autonomous AI Eye Screening Technology

Los Angeles, USA and Copenhagen, Denmark, Sept. 17, 2025 (GLOBE NEWSWIRE) -- – Eyenuk, a global leader in AI-powered eye screening, today announced that its EyeArt® AI Eye Screening System has been...
September 17, 2025 07:00 ET | Source: Lexicon Pharmaceuticals, Inc.

Pilavapadin Provides Meaningful Pain Reduction in Adults with Diabetic Peripheral Neuropathic Pain (DPNP) in Data Presented at the European Association for the Study of Diabetes (EASD) and NEUROdiab Annual Meetings

THE WOODLANDS, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the presentation of clinical data from the company’s Phase 2b PROGRESS study for...
September 11, 2025 06:30 ET | Source: Teleflex Incorporated

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

WAYNE, Pa., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the enrollment of the first patient in the...
September 08, 2025 08:30 ET | Source: UMeWorld Limited

UMeWorld Expands Growth Strategy with DAGola China Launch, Biofuel Pilot Plant, and Future SAF Potential

Company highlights DAGola™ cooking oil expansion into China, progress on Malaysia biofuel pilot plant, future potential in Sustainable Aviation Fuel (SAF)
September 03, 2025 08:19 ET | Source: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use

10-minute home test detects early kidney damage in diabetic and hypertensive patientsHypertension affects roughly one-third of adults in the UAEDiabetes impacts approximately one in four UAE nationals...
August 21, 2025 12:30 ET | Source: Custom Market Insights

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Biologics and Biosimilars Market Size, Trends and Insights By Product Type...
August 14, 2025 16:00 ET | Source: Heald

Heald Launches First Money-Back Guarantee in Digital Diabetes Reversal

ALPHARETTA, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Heald, a pioneering digital health company specializing in Type 2 diabetes reversal through personalized lifestyle interventions, today announced a...
August 07, 2025 07:30 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates